Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.

BMC cancer - 20 Jan 2021

Liu Feng-Min, Gao Yu-Fei, Kong Yanyan, Guan Yihui, Zhang Jinsen, Li Shuai-Hong, Ye Dan, Wen Wenyu, Zuo Chuantao, Hua Wei

Abstract excerpt

BACKGROUND: Non-invasive diagnosis of IDH1 mutation for gliomas has great clinical significance, and PET has natural advantage to detect metabolism, as IDH mutated gliomas share lower glucose consumption. METHODS: Clinical data of patients with gliomas and 18F-FDG PET were retrospectively reviewed. Receiver operating characteristic curve (ROC) analysis was conducted, and standard uptake value (SUV) was estimated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Glucose

Share to Isocitrate Dehydrogenase

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 33472598
DOI: 10.1186/s12885-021-07797-6
PMCID: PMC7816361

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.PMID 33472598Read ↗

Metabolism of glioma and IDH1/IDH2 mutations.Semantic proximity Read ↗

Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma.Semantic proximity Read ↗

In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.Semantic proximity Read ↗

A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.Semantic proximity Read ↗

Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of PatientsSemantic proximity Read ↗

Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.Semantic proximity Read ↗

Identification of the key roles of different hexokinases on the diagnosis, prognosis, tumor immunity, drug response: evidence from pan-cancer analysis and construction prognostic HKs signaturesSemantic proximity Read ↗

Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level.Semantic proximity Read ↗

Ketohexokinase is involved in fructose utilization and promotes tumor progression in gliomaSemantic proximity Read ↗

Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.Semantic proximity Read ↗

High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower SurvivalSemantic proximity Read ↗

Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.